Carlson Capital, L.P. - Aug 15, 2023 Form 4 Insider Report for TFF Pharmaceuticals, Inc. (TFFP)

Role
10%+ Owner
Signature
Carlson Capital, L.P., By: /s/ Clint D. Carlson, Title: President
Stock symbol
TFFP
Transactions as of
Aug 15, 2023
Transactions value $
-$94,433
Form type
4
Date filed
8/17/2023, 05:29 PM
Previous filing
Mar 31, 2023
Next filing
Sep 7, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TFFP Common Stock, par value $0.001 per share (the "Common Stock" Sale -$94K -215K -4.07% $0.44 5.07M Aug 15, 2023 See footnotes F1, F2, F3
transaction TFFP Common Stock Sale -$392 -1K -0.02% $0.39 5.06M Aug 16, 2023 See footnotes F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Carlson Capital, L.P. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The transactions referenced herein provide for various per share prices ranging from $0.405886 to $0.46. The Reporting Persons undertake to provide to the Staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased or sold at each separate price.
F2 The shares of Common Stock to which this relates are held directly by Double Black Diamond Offshore Ltd., a Cayman Islands exempted company (the "Fund").
F3 Carlson Capital, L.P., a Delaware limited partnership ("Carlson Capital") serves as the investment manager to, and has the power to direct the affairs of, the Fund. Asgard Investment Corp. II, a Delaware corporation ("Asgard II") serves as the general partner of, and has the power to direct the affairs of, Carlson Capital. Mr. Clint D. Carlson, a U.S. citizen, serves as the president of, and has the power to direct the affairs of, Asgard II and Carlson Capital. Each of the reporting persons disclaims beneficial ownership of the securities to which this Form 4 relates for the purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, except as to such extent of the reporting person's pecuniary interest in the securities.
F4 The transactions referenced herein provide for various per share prices ranging from $0.38 to $0.436. The Reporting Persons undertake to provide to the Staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased or sold at each separate price.